HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD

Overview

HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering ENOXAPARIN SODIUM; HEPARIN SODIUM.

API / Drug Master Files

HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD holds 2 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ENOXAPARIN SODIUMActive2012-07-30
• HEPARIN SODIUMActive2011-01-21
• DALTEPARIN SODIUMInactive2015-03-06
• HEPARIN SODIUM USPInactive2006-02-21

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.